Belgium vs Sweden: Proportion of isolates with decreased susceptibility or resistance
Belgium
2.9
in 2018
Sweden
1.5
in 2018
Belgium rank
7th
Sweden rank
9th
Proportion of isolates with decreased susceptibility or resistance over time
- Belgium
- Sweden
How they compare
Belgium currently reports 2.9 against 1.5 in Sweden, a difference of 1.4.
That makes Belgium's figure about 1.9 times Sweden's.
The two have swapped places 4 times across 10 shared years of data; in 2009 it was Belgium ahead.
Belgium ranks 7th and Sweden ranks 9th of 27 countries.
Belgium has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belgium | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.36 | 2.78 | 3.59 | Belgium |
| 2010s | 5.34 | 2.03 | 3.31 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Belgium or Sweden?
- Belgium, at 2.9 against 1.5 in Sweden as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Belgium and Sweden?
- 1.4, with Belgium ahead.
- How many years of comparable data are there for Belgium and Sweden?
- 10 years are reported by both, from 2009 to 2018.
- How do Belgium and Sweden rank globally for proportion of isolates with decreased susceptibility or resistance?
- Belgium ranks 7th and Sweden ranks 9th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.